Literature DB >> 20595357

Global health, equity and the WHO Framework Convention on Tobacco Control.

Jeff Collin1.   

Abstract

The report of the WHO Commission on Social Determinants of Health demonstrates the renewed salience of health inequalities within the international health policy agenda. The tobacco pandemic is characterized by an escalating burden of death and disease that is increasingly being borne by developing countries. Efforts to promote global health equity must therefore prioritize reductions in tobacco consumption. The WHO Framework Convention on Tobacco Control (FCTC) offers a remarkable opportunity to address the health inequalities associated with tobacco use, and represents an important innovation within global governance. But the FCTC's failure to adequately address the health impacts of trade liberalization highlights the difficulties of ensuring policy coherence across international health, development and economic policies. Recognition of such limitations is important both to inform the further development of the FCTC and to ensure that appropriate lessons are drawn for future initiatives.

Entities:  

Mesh:

Year:  2010        PMID: 20595357      PMCID: PMC4474151          DOI: 10.1177/1757975909358363

Source DB:  PubMed          Journal:  Glob Health Promot        ISSN: 1757-9759


  8 in total

1.  The future of the global tobacco treaty negotiations.

Authors:  Henry A Waxman
Journal:  N Engl J Med       Date:  2002-03-15       Impact factor: 91.245

2.  Closing the gap in a generation: health equity through action on the social determinants of health. A report of the WHO Commission on Social Determinants of Health (CSDH) 2008.

Authors:  Aubrey Sheiham
Journal:  Community Dent Health       Date:  2009-03       Impact factor: 1.349

Review 3.  Marketing to the marginalised: tobacco industry targeting of the homeless and mentally ill.

Authors:  D E Apollonio; R E Malone
Journal:  Tob Control       Date:  2005-12       Impact factor: 7.552

4.  Tobacco control policies are egalitarian: a vulnerabilities perspective on clean indoor air laws, cigarette prices, and tobacco use disparities.

Authors:  Alexis Dinno; Stanton Glantz
Journal:  Soc Sci Med       Date:  2009-03-11       Impact factor: 4.634

5.  Global health priorities - priorities of the wealthy?

Authors:  Eeva Ollila
Journal:  Global Health       Date:  2005-04-22       Impact factor: 4.185

6.  Projections of global mortality and burden of disease from 2002 to 2030.

Authors:  Colin D Mathers; Dejan Loncar
Journal:  PLoS Med       Date:  2006-11       Impact factor: 11.069

7.  Effect of tobacco smoking on survival of men and women by social position: a 28 year cohort study.

Authors:  Laurence Gruer; Carole L Hart; David S Gordon; Graham C M Watt
Journal:  BMJ       Date:  2009-02-17

Review 8.  Population tobacco control interventions and their effects on social inequalities in smoking: systematic review.

Authors:  S Thomas; D Fayter; K Misso; D Ogilvie; M Petticrew; A Sowden; M Whitehead; G Worthy
Journal:  Tob Control       Date:  2008-04-21       Impact factor: 7.552

  8 in total
  4 in total

1.  To 'enable our legal product to compete effectively with the transit market': British American Tobacco's strategies in Thailand following the 1990 GATT dispute.

Authors:  Ross MacKenzie; Kelley Lee; Eric LeGresley
Journal:  Glob Public Health       Date:  2015-08-21

2.  Tobacco control, global health policy and development: towards policy coherence in global governance.

Authors:  Jeff Collin
Journal:  Tob Control       Date:  2012-03       Impact factor: 7.552

Review 3.  Current Cigarette Smoking and Its Predictors among School-Going Adolescents in East Africa: A Systematic Review and Meta-Analysis.

Authors:  Nega Tezera; Aklilu Endalamaw
Journal:  Int J Pediatr       Date:  2019-05-08

4.  Health and health-care systems in southeast Asia: diversity and transitions.

Authors:  Virasakdi Chongsuvivatwong; Kai Hong Phua; Mui Teng Yap; Nicola S Pocock; Jamal H Hashim; Rethy Chhem; Siswanto Agus Wilopo; Alan D Lopez
Journal:  Lancet       Date:  2011-01-29       Impact factor: 79.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.